BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25373609)

  • 1. What can pharmacists' do about the Medicare Part D Donut hole and reimbursement? A six-state survey.
    Khan S
    Aging Clin Exp Res; 2015 Jun; 27(3):373-81. PubMed ID: 25373609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare Part D: Pharmacists and formularies--whose job is it to address copays?
    Khan S
    Consult Pharm; 2014 Sep; 29(9):602-13. PubMed ID: 25203409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Do Pharmacists Assist Medicare Beneficiaries with Limited Income? A Cross-Sectional Study of Community Pharmacies in Alabama.
    Westrick SC; Hastings TJ; McFarland SJ; Hohmann LA; Hohmann NS
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1039-45. PubMed ID: 27579825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional Variation in Pharmacist Perception of the Financial Impact of Medicare Part D.
    Khan S; Spooner JJ; Spotts HE
    Pharmacy (Basel); 2018 Jul; 6(3):. PubMed ID: 30018243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior.
    Herbert KE; Urmie JM; Newland BA; Farris KB
    Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy language assistance resources and their association with pharmacists' self-efficacy in communicating with Spanish-speaking patients.
    Devraj R; Young HN
    Res Social Adm Pharm; 2017; 13(1):123-132. PubMed ID: 27021260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of patients' and pharmacists' satisfaction with medication counseling provided by community pharmacies: a cross-sectional survey.
    Yang S; Kim D; Choi HJ; Chang MJ
    BMC Health Serv Res; 2016 Apr; 16():131. PubMed ID: 27080704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries.
    Berenbrok LA; Gabriel N; Coley KC; Hernandez I
    JAMA Netw Open; 2020 Jul; 3(7):e209132. PubMed ID: 32667653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Financial hardship from purchasing prescription drugs among older adults in the United States before, during, and after the Medicare Part D "Donut Hole": Findings from 1998, 2001, 2015, and 2021.
    Olson AW; Schommer JC; Mott DA; Adekunle O; Brown LM
    J Manag Care Spec Pharm; 2022 May; 28(5):508-517. PubMed ID: 35471065
    [No Abstract]   [Full Text] [Related]  

  • 17. Community pharmacists' interest in and attitude to pharmacy practice research in Ethiopia: A cross-sectional study.
    Bhagavathula AS; Gebreyohannes EA; Gebresillassie BM; Erku DA; Negesse CT; Belay YB
    PLoS One; 2017; 12(6):e0178919. PubMed ID: 28617834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pharmacists or pharmacies as Medicare Part D information sources.
    Kennelty KA; Thorpe JM; Chewning B; Mott DA
    J Am Pharm Assoc (2003); 2012; 52(6):e205-9. PubMed ID: 23229982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.